Article Details

UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients ...

Retrieved on: 2021-07-07 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients .... View article details on hiswai:

Excerpt

SOUTH SAN FRANCISCO, CA, USA I July 06, 2021 I UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up